Your browser doesn't support javascript.
loading
In vitro bone metastasis dwelling in a 3D bioengineered niche.
Han, Weijing; El Botty, Rania; Montaudon, Elodie; Malaquin, Laurent; Deschaseaux, Frederic; Espagnolle, Nicolas; Marangoni, Elisabetta; Cottu, Paul; Zalcman, Gérard; Parrini, Maria Carla; Assayag, Franck; Sensebe, Luc; Silberzan, Pascal; Vincent-Salomon, Anne; Dutertre, Guillaume; Roman-Roman, Sergio; Descroix, Stephanie; Camonis, Jacques.
Afiliación
  • Han W; Institut Curie, Centre de Recherche, Paris Sciences et Lettres Research University, 75005, Paris, France; ART Group, Inserm U830, 75005, Paris, France; Laboratoire PhysicoChimie Curie, Institut Curie, PSL Research University - Sorbonne Université - CNRS. Equipe Labellisée Ligue Contre le Cancer; 750
  • El Botty R; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL Research University, 75005, Paris, France.
  • Montaudon E; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL Research University, 75005, Paris, France.
  • Malaquin L; LAAS-CNRS, Université de Toulouse, CNRS, F-31400, Toulouse, France.
  • Deschaseaux F; STROMALab, Etablissement Français Du Sang-Occitanie (EFS), Inserm 1031, University of Toulouse, ERL5311 CNRS, National Veterinary School of Toulouse (ENVT), Toulouse, France.
  • Espagnolle N; STROMALab, Etablissement Français Du Sang-Occitanie (EFS), Inserm 1031, University of Toulouse, ERL5311 CNRS, National Veterinary School of Toulouse (ENVT), Toulouse, France.
  • Marangoni E; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL Research University, 75005, Paris, France.
  • Cottu P; Department of Medical Oncology, Institut Curie and Paris Sciences et Lettres Research University, 75005, Paris, France.
  • Zalcman G; Institut Curie, Centre de Recherche, Paris Sciences et Lettres Research University, 75005, Paris, France; ART Group, Inserm U830, 75005, Paris, France; Thoracic Oncology Department and Early Phase Unit CIC-1425, Hôpital Bichat, AP-HP, Université de Paris, 75018, Paris, France.
  • Parrini MC; Institut Curie, Centre de Recherche, Paris Sciences et Lettres Research University, 75005, Paris, France; ART Group, Inserm U830, 75005, Paris, France.
  • Assayag F; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL Research University, 75005, Paris, France.
  • Sensebe L; STROMALab, Etablissement Français Du Sang-Occitanie (EFS), Inserm 1031, University of Toulouse, ERL5311 CNRS, National Veterinary School of Toulouse (ENVT), Toulouse, France.
  • Silberzan P; Laboratoire PhysicoChimie Curie, Institut Curie, PSL Research University - Sorbonne Université - CNRS. Equipe Labellisée Ligue Contre le Cancer; 75005, Paris, France.
  • Vincent-Salomon A; Department of Pathology, Institut Curie Hospital, 26, Rue D'Ulm, F-75248, Paris, France.
  • Dutertre G; Surgical Oncology Department, Institut Curie, PSL Research University, 75005, Paris, France.
  • Roman-Roman S; Translational Research Department, Institut Curie, PSL Research University, 75005, Paris, France.
  • Descroix S; Laboratoire PhysicoChimie Curie, Institut Curie, PSL Research University - Sorbonne Université - CNRS. Equipe Labellisée Ligue Contre le Cancer; 75005, Paris, France. Electronic address: Stephanie.descroix@curie.fr.
  • Camonis J; Institut Curie, Centre de Recherche, Paris Sciences et Lettres Research University, 75005, Paris, France; ART Group, Inserm U830, 75005, Paris, France. Electronic address: jacques.camonis@curie.fr.
Biomaterials ; 269: 120624, 2021 02.
Article en En | MEDLINE | ID: mdl-33421710
ABSTRACT
Bone is the most frequent metastasis site for breast cancer. As well as dramatically increasing disease burden, bone metastases are also an indicator of poor prognosis. One of the main challenges in investigating bone metastasis in breast cancer is engineering in vitro models that replicate the features of in vivo bone environments. Such in vitro models ideally enable the biology of the metastatic cells to mimic their in vivo behavior as closely as possible. Here, taking benefit of cutting-edge technologies both in microfabrication and cancer cell biology, we have developed an in vitro breast cancer bone-metastasis model. To do so we first 3D printed a bone scaffold that reproduces the trabecular architecture and that can be conditioned with osteoblast-like cells, a collagen matrix, and mineralized calcium. We thus demonstrated that this device offers an adequate soil to seed primary breast cancer bone metastatic cells. In particular, patient-derived xenografts being considered as a better approach than cell lines to achieve clinically relevant results, we demonstrate the ability of this biomimetic bone niche model to host patient-derived xenografted metastatic breast cancer cells. These patient-derived xenograft cells show a long-term survival in the bone model and maintain their cycling propensity, and exhibit the same modulated drug response as in vivo. This experimental system enables access to the idiosyncratic features of the bone microenvironment and cancer bone metastasis, which has implications for drug testing.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Neoplasias de la Mama Límite: Animals / Humans Idioma: En Revista: Biomaterials Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Neoplasias de la Mama Límite: Animals / Humans Idioma: En Revista: Biomaterials Año: 2021 Tipo del documento: Article
...